dihexa (PNB-0408) | C27H44N4O5 | CID 125355097 DIHEXA Peptide - VANDL
Description
Organic Letters 2025 , 27 (44) , 12385-12390
doi: 10.1038/nrdp.2017.34
If administered by injection, local reactions such as redness, swelling, itching, or pain can occur, and improper technique can increase infection risk
We found no selectivity towards senescent IMR90 (Fig
were employees of Autobahn Therapeutics and hold equity interests in the company
The product integrates easily into our standard lab procedures and the documentation provided is clear
